Renal Resistive Index as an Indicator of Lupus Nephritis Severity and Systemic Lupus Activity
1 other identifier
interventional
75
1 country
1
Brief Summary
The study explores the role of the colour Doppler scanning of the renal arteries and its relation to the degree of disease affection in lupus nephritis
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 3, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 13, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
October 15, 2023
CompletedFirst Submitted
Initial submission to the registry
December 27, 2024
CompletedFirst Posted
Study publicly available on registry
January 3, 2025
CompletedJanuary 3, 2025
December 1, 2024
1.1 years
December 27, 2024
December 27, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Resistive index
The resistive index of the renal arteries as measured by the colour Doppler
At the time of recruitment
Study Arms (3)
Patients with lupus nephritis
ACTIVE COMPARATORTheses are 25 patients diagnosed with lupus nephritis
Lupus without nephritis
ACTIVE COMPARATORTheses are 25 patients diagnosed with lupus without evidence of nephritis
Healthy control
NO INTERVENTIONPatients who are healthy volunteers with no evidence of nephritis or systemic lupus
Interventions
using colour doppler to asses vascular resistance and resistive index
Eligibility Criteria
You may qualify if:
- \. Systemic lupus erythematosus. 2. Lupus nephritis. 3. Adults \>18 years old.
You may not qualify if:
- \. End Stage Renal Disease. 2. Diabetes Mellitus. 3. Heart failure. 4. Hepatic diseases. 5. Obstructive nephropathy. 6. Renal artery stenosis or occlusion.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Cairo University Hospitals
Cairo, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate professor of Internal medicine and nephrology
Study Record Dates
First Submitted
December 27, 2024
First Posted
January 3, 2025
Study Start
September 3, 2022
Primary Completion
October 13, 2023
Study Completion
October 15, 2023
Last Updated
January 3, 2025
Record last verified: 2024-12